FSD Pharma Chairman & CEO to Present at 22nd Annual BIO CEO & Investor Conference in NYC
FSD Pharma Inc. - Class B Subordinate Voting Shares (HUGE)
Company Research
Source: Business Wire
TORONTO--(BUSINESS WIRE)--FSD Pharma Inc. (NASDAQ: HUGE) (CSE: HUGE) (FRA: 0K9A) ("FSD Pharma" or the "Company") announces that Raza Bokhari, MD, Executive Co-Chairman and Chief Executive Officer, accompanied by FSD Pharma Biosciences leadership, will be participating in the 22nd Annual BIO CEO & Investor conference, including presenting a company overview at 9:45 a.m. ET on Monday, February 10, 2020.About BIO CEO & Investor ConferenceThe BIO CEO & Investor Conference is one of the largest investor conferences focused on established and emerging publicly traded and select private biotech companies. The event features issue-oriented plenary sessions, educational sessions focused on hot therapeutic areas and key business issues, company presentations, one-on-one meetings, and networking opportunities.About FSD PharmaFSD Pharma is a specialty biotech pharmaceutical R&D company focused on developing over time a robust pipeline of FDA-approved synthetic compounds targeting the endocann
Show less
Read more
Impact Snapshot
Event Time:
HUGE
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
---|---|---|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
Last Price | ||
VWAP | ||
High:
|
Max Up |
High:
|
Low:
|
Max Down |
Low:
|
%
|
Post news range |
%
|
|
Price change |
|
|
Price Change Percentage |
|
|
S&P 500 (SPX) |
|
%
|
Volume ratio |
%
|
Volume | ||
Ticks | ||
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
HUGE alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
HUGE alerts
High impacting FSD Pharma Inc. - Class B Subordinate Voting Shares news events
Weekly update
A roundup of the hottest topics
HUGE
News
- FSD Pharma Signs Agreement with Applied Science and Performance Institute (ASPI) to Conduct a Clinical Trial in the United States to Assess the Safety and Efficacy of unbuzzd(TM) in an Induced State of Alcohol IntoxicationAccesswire
- FSD Pharma Provides Update from Celly Nu’s Partnership with Six+One for unbuzzd(TM)Accesswire
- FSD Pharma Provides Another Update on Celly Nu's Anticipated Launch of unbuzzd(TM) [Yahoo! Finance]Yahoo! Finance
- FSD Pharma Provides Another Update on Celly Nu's Anticipated Launch of unbuzzd(TM)Accesswire
- FSD Pharma Expands Investigative Pipeline to Include Potential Weight Loss and Liver Health Formulations and Products [Yahoo! Finance]Yahoo! Finance
HUGE
Sec Filings
- 4/30/24 - Form 6-K
- 4/25/24 - Form 6-K
- 4/22/24 - Form 6-K
- HUGE's page on the SEC website